• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见出血性疾病中的分子缺陷:遗传性出血性毛细血管扩张症

Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia.

作者信息

Shovlin C L

机构信息

Department of Genetics, Harvard Medical School, Boston, MA, USA.

出版信息

Thromb Haemost. 1997 Jul;78(1):145-50.

PMID:9198145
Abstract

Vascular diseases may mimic coagulopathies by presenting as a haemorrhagic state. The archetypal example of an inherited disorder resulting in haemorrhage from dilated vessels of the microvasculature (telangiectasia) is Hereditary Haemorrhagic Telangiectasia (HHT, Rendu-Osler-Weber syndrome). This autosomal dominant disorder is characterised by haemorrhage from nasal, mucocutaneous and gastrointestinal telangiectasia, in addition to vascular anomalies in other organs, particularly in the pulmonary, hepatic and cerebral circulations. Linkage analyses have indicated there are at least three HHT loci, including the genes for endoglin on chromosome 9, and activin-like receptor kinase (ALK1) on chromosome 12. Mutations in these genes, together with recent data on the normal function of the encoded proteins highlight the role of TGF-b family members in the pathogenesis of HHT. Complimentary information from other telangiectatic states indicates potential precipitants, and indicate a critical role for TGF-beta ligand-receptor interactions in vascular homeostasis.

摘要

血管疾病可能通过表现为出血状态而类似凝血障碍。导致微血管扩张血管(毛细血管扩张)出血的遗传性疾病的典型例子是遗传性出血性毛细血管扩张症(HHT,伦杜-奥斯勒-韦伯综合征)。这种常染色体显性疾病的特征是鼻腔、黏膜皮肤和胃肠道毛细血管扩张出血,此外其他器官也存在血管异常,特别是在肺循环、肝循环和脑循环中。连锁分析表明至少有三个HHT基因座,包括9号染色体上的内皮素基因和12号染色体上的激活素样受体激酶(ALK1)。这些基因的突变,以及关于所编码蛋白质正常功能的最新数据,突出了转化生长因子-β(TGF-β)家族成员在HHT发病机制中的作用。来自其他毛细血管扩张状态的补充信息表明了潜在的诱发因素,并表明TGF-β配体-受体相互作用在血管稳态中起关键作用。

相似文献

1
Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia.罕见出血性疾病中的分子缺陷:遗传性出血性毛细血管扩张症
Thromb Haemost. 1997 Jul;78(1):145-50.
2
A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.一个患有肺部受累的遗传性出血性毛细血管扩张症家族与已知的HHT基因、内皮糖蛋白和ALK-1不连锁。
Thorax. 2000 Aug;55(8):685-90. doi: 10.1136/thorax.55.8.685.
3
The molecular genetics of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的分子遗传学
Chest. 1997 Jun;111(6 Suppl):79S-82S. doi: 10.1378/chest.111.6_supplement.79s.
4
Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.遗传性出血性毛细血管扩张症:一项基于问卷的研究,以描述由内皮素和ALK1突变引起的不同表型。
J Med Genet. 2003 Aug;40(8):585-90. doi: 10.1136/jmg.40.8.585.
5
Genetic abnormalities in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中的基因异常
Curr Opin Hematol. 1998 Sep;5(5):332-8. doi: 10.1097/00062752-199809000-00005.
6
Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的遗传和分子发病机制
J Med Invest. 2000 Aug;47(3-4):81-90.
7
Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.遗传性出血性毛细血管扩张症患者的血源内皮祖细胞显示出与血管病变相符的异常。
Cardiovasc Res. 2005 Nov 1;68(2):235-48. doi: 10.1016/j.cardiores.2005.06.009. Epub 2005 Jul 5.
8
Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.遗传性出血性毛细血管扩张症,一种影响转化生长因子-β信号通路的血管发育异常疾病。
Clin Med Res. 2006 Mar;4(1):66-78. doi: 10.3121/cmr.4.1.66.
9
Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.对患有2型遗传性出血性毛细血管扩张症家庭新生儿中ALK-1和内皮糖蛋白的分析。
Hum Mol Genet. 2000 May 1;9(8):1227-37. doi: 10.1093/hmg/9.8.1227.
10
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.2型遗传性出血性毛细血管扩张症中激活素受体样激酶1基因的突变
Nat Genet. 1996 Jun;13(2):189-95. doi: 10.1038/ng0696-189.

引用本文的文献

1
Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia.氨甲环酸可能是一种治疗内镜治疗抵抗性小肠血管扩张症的有效药物治疗方法。
World J Gastroenterol. 2023 Feb 21;29(7):1131-1138. doi: 10.3748/wjg.v29.i7.1131.
2
Actin Cytoskeleton and Regulation of TGFβ Signaling: Exploring Their Links.肌动蛋白细胞骨架与 TGFβ 信号转导的调控:探索它们之间的联系。
Biomolecules. 2021 Feb 23;11(2):336. doi: 10.3390/biom11020336.
3
ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.ALK1 信号通过与 Notch 通路合作抑制血管生成。
Dev Cell. 2012 Mar 13;22(3):489-500. doi: 10.1016/j.devcel.2012.02.005.
4
Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia.
Lasers Med Sci. 2006 Sep;21(3):140-6. doi: 10.1007/s10103-006-0389-7. Epub 2006 Jul 29.
5
Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.2型遗传性出血性毛细血管扩张症的内脏表现
J Med Genet. 2003 Jul;40(7):494-502. doi: 10.1136/jmg.40.7.494.
6
Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.在正常血管中内皮糖蛋白表达降低,但在遗传性出血性毛细血管扩张症1型患者的动静脉畸形中仍可检测到。
Am J Pathol. 2000 Mar;156(3):911-23. doi: 10.1016/S0002-9440(10)64960-7.
7
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.遗传性出血性毛细血管扩张症与肺动静脉畸形:临床管理问题及致病机制综述
Thorax. 1999 Aug;54(8):714-29. doi: 10.1136/thx.54.8.714.
8
Expression of normal and truncated forms of human endoglin.人内皮糖蛋白正常形式和截短形式的表达
Biochem J. 1999 May 1;339 ( Pt 3)(Pt 3):579-88.
9
Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.1型遗传性出血性毛细血管扩张症中的突变内皮糖蛋白在细胞内短暂表达,并非显性负性蛋白。
J Clin Invest. 1997 Nov 15;100(10):2568-79. doi: 10.1172/JCI119800.